Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
$6.31
-24.8%
$5.59
$0.23
$14.11
$229.01M1.71394,406 shs2.75 million shs
Myomo, Inc. stock logo
MYO
Myomo
$2.21
+5.7%
$2.98
$2.02
$7.17
$75.20M1.39401,224 shs336,209 shs
The Beauty Health Company stock logo
SKIN
Beauty Health
$2.09
-0.5%
$1.68
$0.78
$2.38
$264.59M1.22966,016 shs756,124 shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$9.49
-1.5%
$9.07
$8.15
$22.40
$268.17M2.07190,798 shs112,023 shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
-24.79%-34.61%+0.16%+942.98%+1,547.52%
Myomo, Inc. stock logo
MYO
Myomo
+5.74%+6.25%-25.59%-48.48%-52.47%
The Beauty Health Company stock logo
SKIN
Beauty Health
-0.48%-0.95%+30.63%+109.00%+11.17%
ZimVie Inc. stock logo
ZIMV
ZimVie
-1.45%-5.19%+1.06%+4.63%-47.68%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
1.1039 of 5 stars
2.50.00.00.01.90.80.6
Myomo, Inc. stock logo
MYO
Myomo
3.3017 of 5 stars
3.54.00.00.02.42.50.6
The Beauty Health Company stock logo
SKIN
Beauty Health
0.3419 of 5 stars
0.80.00.00.02.23.30.0
ZimVie Inc. stock logo
ZIMV
ZimVie
1.9249 of 5 stars
3.33.00.00.00.01.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
3.00
Buy$10.0058.48% Upside
Myomo, Inc. stock logo
MYO
Myomo
3.00
Buy$9.67337.41% Upside
The Beauty Health Company stock logo
SKIN
Beauty Health
1.67
Reduce$1.42-32.22% Downside
ZimVie Inc. stock logo
ZIMV
ZimVie
2.67
Moderate Buy$16.3372.11% Upside

Current Analyst Ratings Breakdown

Latest MYO, SKIN, ZIMV, and BSGM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/26/2025
Myomo, Inc. stock logo
MYO
Myomo
Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
6/23/2025
Myomo, Inc. stock logo
MYO
Myomo
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$10.00 ➝ $8.00
6/6/2025
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$2.50 ➝ $10.00
6/5/2025
Myomo, Inc. stock logo
MYO
Myomo
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$11.00 ➝ $11.50
5/15/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$16.00 ➝ $10.00
5/8/2025
Myomo, Inc. stock logo
MYO
Myomo
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$11.00 ➝ $10.00
5/5/2025
The Beauty Health Company stock logo
SKIN
Beauty Health
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$1.50 ➝ $1.25
4/21/2025
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$2.75 ➝ $2.50
4/10/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$16.00
(Data available from 7/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
$26K6,624.29N/AN/A($0.09) per share-70.11
Myomo, Inc. stock logo
MYO
Myomo
$32.55M2.44N/AN/A$0.82 per share2.70
The Beauty Health Company stock logo
SKIN
Beauty Health
$334.30M0.79$0.06 per share33.21$0.41 per share5.10
ZimVie Inc. stock logo
ZIMV
ZimVie
$449.75M0.59$1.83 per share5.18$13.83 per share0.69
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
-$10.33MN/A0.00N/AN/AN/A-5,336.99%-398.16%8/13/2025 (Estimated)
Myomo, Inc. stock logo
MYO
Myomo
-$6.18M-$0.23N/AN/AN/A-15.05%-35.57%-20.11%8/5/2025 (Estimated)
The Beauty Health Company stock logo
SKIN
Beauty Health
-$29.10M-$0.41N/AN/AN/A-11.94%-67.91%-5.56%8/6/2025 (Estimated)
ZimVie Inc. stock logo
ZIMV
ZimVie
-$25.83M-$0.71N/AN/A-4.40%5.53%2.84%7/31/2025 (Estimated)

Latest MYO, SKIN, ZIMV, and BSGM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2025Q2 2025
Myomo, Inc. stock logo
MYO
Myomo
-$0.11N/AN/AN/AN/AN/A
7/31/2025Q2 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.2285N/AN/AN/A$112.82 millionN/A
5/19/2025Q1 2025
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
-$0.05-$0.14-$0.09-$0.14N/AN/A
5/8/2025Q1 2025
The Beauty Health Company stock logo
SKIN
Beauty Health
-$0.13-$0.08+$0.05-$0.08$63.88 million$69.60 million
5/8/2025Q1 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.21$0.27+$0.06-$0.05$113.10 million$112.00 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
N/AN/AN/AN/AN/A
Myomo, Inc. stock logo
MYO
Myomo
N/AN/AN/AN/AN/A
The Beauty Health Company stock logo
SKIN
Beauty Health
N/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
N/A
2.37
2.37
Myomo, Inc. stock logo
MYO
Myomo
N/A
2.66
2.37
The Beauty Health Company stock logo
SKIN
Beauty Health
12.01
7.47
6.43
ZimVie Inc. stock logo
ZIMV
ZimVie
0.58
2.14
1.48

Institutional Ownership

CompanyInstitutional Ownership
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
7.16%
Myomo, Inc. stock logo
MYO
Myomo
44.99%
The Beauty Health Company stock logo
SKIN
Beauty Health
93.26%
ZimVie Inc. stock logo
ZIMV
ZimVie
95.63%

Insider Ownership

CompanyInsider Ownership
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
17.03%
Myomo, Inc. stock logo
MYO
Myomo
4.79%
The Beauty Health Company stock logo
SKIN
Beauty Health
41.00%
ZimVie Inc. stock logo
ZIMV
ZimVie
3.01%
CompanyEmployeesShares OutstandingFree FloatOptionable
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
5027.30 million22.65 millionNo Data
Myomo, Inc. stock logo
MYO
Myomo
9035.98 million34.26 millionNot Optionable
The Beauty Health Company stock logo
SKIN
Beauty Health
1,030125.99 million74.34 millionOptionable
ZimVie Inc. stock logo
ZIMV
ZimVie
1,77027.85 million27.01 millionOptionable

Recent News About These Companies

ZimVie: Screening Cheap (Rating Upgrade)
ZimVie Inc. (ZIMV) Q1 2025 Earnings Call Transcript
ZimVie Reports First Quarter 2025 Financial Results
Q1 2025 ZimVie Inc Earnings Call
ZimVie announces launch of its Immediate Molar Implant system in US
ZimVie launches molar implant system
Needham Remains a Hold on ZimVie Inc (ZIMV)
ZimVie initiated with a Buy at B. Riley

New MarketBeat Followers Over Time

Media Sentiment Over Time

Biosig Technologies stock logo

Biosig Technologies NASDAQ:BSGM

$6.31 -2.08 (-24.79%)
Closing price 07/9/2025 04:00 PM Eastern
Extended Trading
$6.20 -0.11 (-1.76%)
As of 07:22 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

Myomo stock logo

Myomo NYSEAMERICAN:MYO

$2.21 +0.12 (+5.74%)
Closing price 07/9/2025 04:10 PM Eastern
Extended Trading
$2.24 +0.03 (+1.36%)
As of 07:16 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Beauty Health stock logo

Beauty Health NASDAQ:SKIN

$2.09 -0.01 (-0.48%)
Closing price 07/9/2025 04:00 PM Eastern
Extended Trading
$2.02 -0.07 (-3.35%)
As of 05:57 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.

ZimVie stock logo

ZimVie NASDAQ:ZIMV

$9.49 -0.14 (-1.45%)
As of 07/9/2025 04:00 PM Eastern

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.